Call Now

Acute Megakaryoblastic Leukemia Cells (AMKLC)

Acute megakaryoblastic leukemia (AMKL) is a form of leukemia where a majority of the blasts are megakaryoblastic. It is classified under AML-M7 category of the French-American-British classification. It is associated with GATA1, and risks are increased in individuals with Down syndrome. A megakaryoblastic cell line, designated MEG-01, was established from the bone marrow of a patient with blast crisis of Philadelphia (Ph1) chromosome-positive chronic myelogenous leukemia. MEG-01 cell line may provide a useful model for the study of human megakaryopoiesis and of the biosynthetic mechanisms of proteins unique to megakaryocytic lineage.

Organism species: Pan-species (General)

PRODUCT TYPE CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins N/A Recombinant Acute Megakaryoblastic Leukemia Cells (AMKLC) Antigenic Transformation Customized Service Offer
Antibodies N/A Monoclonal Antibody to Acute Megakaryoblastic Leukemia Cells (AMKLC) Monoclonal Antibody Customized Service Offer
N/A Polyclonal Antibody to Acute Megakaryoblastic Leukemia Cells (AMKLC) Polyclonal Antibody Customized Service Offer
Assay Kits N/A CLIA Kit for Acute Megakaryoblastic Leukemia Cells (AMKLC) CLIA Kit Customized Service Offer
N/A ELISA Kit for Acute Megakaryoblastic Leukemia Cells (AMKLC) ELISA Kit Customized Service Offer